title: Studies on the mechanism whereby cyclosporin A inhibits T-lymphocyte activation.
abstract: The immunosuppressive drug Cyclosporin A (CyA) inhibited the ConA-induced DNA synthesis in C57B1/6 spleen cells at a concentration of 40 ng/ml totally; this inhibition could not be overcome by the addition of highly purified interleukin-1. ConA-induced RNA synthesis was also inhibited by concentrations of 40 or 200 ng/ml CyA, although total inhibition could not be achieved. In contrast, lipopolysaccharide-induced proliferation could not be inhibited. CyA at a concentration of 40 ng/ml also inhibited the ConA-induced production of interleukin-2 by mouse spleen cells, this inhibition was not due to a toxic mechanism. On the contrary, the proliferative response of T cell blasts from a long-term T cell line (M2) to interleukin-2 containing supernatants was not inhibited by concentrations of 40 or 200 ng/ml CyA; only at 20-100-fold higher concentrations partial inhibition could be observed. One of the earliest events in the course of lymphocyte activation, the enhanced incorporation of unsaturated fatty acids into the lymphocyte plasma membranes; was also inhibited by concentrations of CyA, which abrogated the ConA-induced DNA synthesis. The inhibition of the enhanced incorporation of 14C-oleic acid and 14C-linoleic acid, which are incorporated by the membrane-bound lysolecithin-acyltransferase, thus suggests a molecular site of action for CyA.
authors.forename: M
authors.initials: M
authors.lastname: Stoeck
authors.forename: K
authors.initials: K
authors.lastname: Wildhagen
authors.forename: M
authors.initials: M
authors.lastname: Szamel
authors.forename: D
authors.initials: D
authors.lastname: Lovett
authors.forename: K
authors.initials: K
authors.lastname: Resch
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D003524:Cyclosporins / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis; D007375:Interleukin-1 / Q000494:pharmacology; D007376:Interleukin-2 / Q000096:biosynthesis; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects*; D008563:Membrane Lipids / Q000378:metabolism; D051379:Mice; D008934:Mitogens / Q000037:antagonists & inhibitors; D019301:Oleic Acid; D009829:Oleic Acids / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
chemical_list: D003524:Cyclosporins; D007375:Interleukin-1; D007376:Interleukin-2; D008041:Linoleic Acids; D008563:Membrane Lipids; D008934:Mitogens; D009829:Oleic Acids; D010743:Phospholipids; D019301:Oleic Acid; D012313:RNA; D004247:DNA; D019787:Linoleic Acid